We are live on ! Find out more
RT

Robert Torray Torray Investment Partners

AUM $741M
1-Year Est. Return 26.16%
 

Robert Torray is the founder of Torray, a long-standing value-oriented investment firm. Torray strategies have historically emphasized careful stock selection, margin of safety, and multi-year holding periods. The firm remains part of the classic U.S. value-manager set tracked through public disclosures.

This Fund
S&P 500
This Quarter Est. Return
+1.48%
1 Year Est. Return
+26.16%
3 Year Est. Return
+82.37%
5 Year Est. Return
+102.19%
10 Year Est. Return
+343.59%
AUM
$939M
AUM Growth
+$28M
Cap. Flow
+$21.4M
Cap. Flow %
2.28%
Top 10 Hldgs %
23.5%
Holding
114
New
29
Increased
39
Reduced
36
Closed
4

Top Buys

Rank Stock Value
1
AYI icon
Acuity Brands
AYI
+$13.6M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.78M
3
CERN
Cerner Corp
CERN
+$3.79M
4
LKQ icon
LKQ Corp
LKQ
+$3.36M
5
GCI
Gannett Co., Inc
GCI
+$3.18M

Top Sells

Rank Stock Value
1
RSG icon
Republic Services
RSG
+$7.22M
2
VMW
VMware, Inc
VMW
+$3.48M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$3.33M
4
AAPL icon
Apple
AAPL
+$2.78M
5
APH icon
Amphenol
APH
+$2.57M

Sector Composition

Rank Sector Weight
1 Technology 20.92%
2 Financials 17.81%
3 Healthcare 15.76%
4 Industrials 13.07%
5 Communication Services 9.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SO icon
101
Southern Company
SO
$102B
$369K 0.04%
7,500
– –
LH icon
102
Labcorp
LH
$27.3B
$340K 0.04%
3,083
+359
+13% +$39.9K
EPD icon
103
Enterprise Products Partners
EPD
$82.1B
$324K 0.03%
12,000
– –
PAGP icon
104
Plains GP Holdings
PAGP
$5.31B
$321K 0.03%
9,254
+673
+8% +$23.1K
EG icon
105
Everest Group
EG
$14.2B
$309K 0.03%
+1,427
New +$294K
RSG icon
106
Republic Services
RSG
$67.6B
$277K 0.03%
4,851
-134,592
-97% -$7.22M
GSK icon
107
GSK
GSK
$105B
$250K 0.03%
5,200
-1,000
-16% -$49.4K
DIS icon
108
Walt Disney
DIS
$186B
$247K 0.03%
2,374
– –
KMI icon
109
Kinder Morgan
KMI
$69B
– –
-10,800
Closed -$250K
PAA icon
110
Plains All American Pipeline
PAA
$17.4B
– –
-14,250
Closed -$448K
VZ icon
111
Verizon
VZ
$205B
– –
-5,102
Closed -$265K
MDVN
112
DELISTED
MEDIVATION, INC.
MDVN
– –
-28,249
Closed -$2.3M
1 2 3 4
5

Similar funds

LGA
Lebenthal Global Advisors Hauppauge, New York $741M AUM 22.36% 1-Year Est. Return
SIC
SFE Investment Counsel Los Angeles, California $742M AUM 39.38% 1-Year Est. Return
CPC
Consolidated Planning Corp Atlanta, Georgia $742M AUM 25.54% 1-Year Est. Return
NC
Northcape Capital Sydney, Australia $742M AUM 2.34% 1-Year Est. Return
TWM
Tolleson Wealth Management Dallas, Texas $742M AUM 17.39% 1-Year Est. Return
WIC
Wilkins Investment Counsel Boston, Massachusetts $742M AUM 23.98% 1-Year Est. Return
NCA
Newbrook Capital Advisors New York $741M AUM 78.82% 1-Year Est. Return
TPM
Triasima Portfolio Management Montreal, Quebec, Canada $740M AUM 69.74% 1-Year Est. Return

Robert Torray's Q4 2016 Portfolio in Review

As of Q4 2016, Robert Torray held 114 positions worth $939M, up 3.1% from $911M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Robert Torray's Q4 2016 filing shows 29 new, 39 increased, 36 reduced and 4 closed positions. Its largest new stake was Acuity Brands: 56,245 shares worth $13M. The largest sale was Republic Services, an estimated $7.22M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.

  • Robert Torray's largest Q4 2016 buy was Acuity Brands: 56,245 shares worth $13M.
  • Robert Torray added most to BioMarin Pharmaceuticals in Q4 2016, an estimated $4.78M increase.
  • Robert Torray's biggest Q4 2016 reduction was Republic Services, cutting an estimated $7.22M.
  • Robert Torray fully exited MEDIVATION, INC. in Q4 2016, selling an estimated $2.3M.
  • Robert Torray's ten largest holdings make up 23% of its $939M portfolio in Q4 2016.
  • Robert Torray opened 29 new positions and closed 4 in Q4 2016.
  • Robert Torray's portfolio value rose 3.1% quarter-over-quarter to $939M.

Based on Torray Investment Partners's 13F filing for Q4 2016, filed 15 Feb 2017.